Exact Sciences clears FDA panel; Roche wins EU nod for subcutaneous Rituxan;

@FierceBiotech: Our 1st EuroBiotech Report: Merck KGaA R&D chief exits, Sobi drug flops in PhIII, Adaptimmune gets full-time CEO. Report | Follow @FierceBiotech

@JohnCFierce: Novartis is using Twitter to support its R&D team at adcomms? Social media won't substitute for another serelaxin trial. More | Follow @JohnCFierce

@DamianFierce: Syndax swings for a $69M IPO with 'breakthrough' drug in tow. News | Follow @DamianFierce

@EmilyMFierce: Report: U.S. can do more to support global health R&D. Article via FierceBiotech Research | Follow @EmilyMFierce

> Exact Sciences ($EXAS) won an FDA panel's unanimous recommendation for its stool-based colorectal cancer diagnostic. News

> Roche ($RHHBY) won European approval for a subcutaneous version of the cancer drug Rituxan. Story

Medical Device News

@FierceMedDev: An analyst thinks Smith & Nephew should split into three pieces, and investors loved the idea. Story | Follow @FierceMedDev

@MarkHFierce: Check out FierceBiotech's debut EuroBiotech report. Report | Follow @MarkHFierce

@MichaelGFierce: Small, drug-releasing battery could dissolve completely over time. Article via FierceDrugDelivery | Follow @MichaelGFierce

@EmilyWFierce: GN Store Nord's U.S. customer base gets a boost thanks to its bluetooth-like hearing aid. Article | Follow @EmilyWFierce

> In Ohio, Steris slashes jobs and plans to close a plant. More

> Exact Sciences wins unanimous FDA committee approval for its colon cancer Dx. News

> NeuroSigma brings on two Amgen execs to bolster its finance team. Item

Pharma News

@FiercePharma: Top-read FP story yesterday: Merck, GlaxoSmithKline halt copay help for Obamacare patients. Story | Follow @FiercePharma

@TracyStaton: RT: Just out: today's full issue of FiercePharmaMarketing. More | Follow @TracyStaton

@EricPFierce: FDA's Woodcock throws cold water on research that found foreign-made generics of Lipitor tainted. Article | Follow @EricPFierce

@CarlyHFierce: Check out FierceBiotech's new EuroBiotech report, which will run every Friday from here on out. Report | Follow @CarlyHFierce

> Roche nabs European approval for time-saving formulation of Rituxan. More

> Hospira puts shareholder lawsuit behind it with $60M settlement. News

> Regeneron clears roadblock for new plant in Irish tax haven. Story